Biotech News
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- <a...
Related news
iSpecimen
iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.
Recent company news
ISPCiSpecimen2025-01-16 16:01 EST
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
ISPCiSpecimen2024-12-20 08:30 EST
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
ISPCiSpecimen2024-12-13 07:30 EST
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
ISPCiSpecimen2024-12-12 17:11 EST
iSpecimen Appoints Robert Lim as CEO and Director
ISPCiSpecimen2024-11-08 07:30 EST
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Stock data
- Close
- 1.69 USD
- Market cap
- 4.41M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States